AI search visibility becomes a strategic digital asset

Tern plc

The way organisations are discovered online is changing, and that shift has direct relevance for businesses that depend on digital authority, brand recognition and trusted content. For many years, the standard path from discovery to commercial action was relatively clear. A person searched for a topic, clicked a result, visited a website and then took some form of measurable action.

Generative AI platforms are altering how people access knowledge. Instead of reviewing a page of search results and choosing which website to visit, users are increasingly receiving direct answers within AI-powered tools. These answers may draw on publicly available content, research, company information or expert commentary, but the user may never visit the original website. This creates a growing category of influence that is difficult to track through traditional analytics.

This development is often described through the idea of invisible clicks. Content can help inform an AI-generated answer, support a recommendation or position a brand within a comparison, while producing no measurable website visit. The influence is real, but the click is absent. This changes the way digital visibility should be assessed. Traffic remains useful, but it may no longer capture the full value of content, authority or brand presence.

Generative Engine Optimisation, or GEO, responds to this shift. While search engine optimisation has traditionally focused on rankings, traffic, click-through rates, backlinks and website performance, GEO is concerned with whether a company’s content is visible, understandable and credible to AI-powered answer engines.

AI tools are increasingly positioned between information and decision-making. A healthcare professional, consumer, employee or business buyer may form an opinion about a company, product or area of expertise before ever reaching a corporate website. That creates both risk and opportunity. Organisations with weak, inconsistent or poorly structured content may become less visible in AI-generated responses. Those with clear, authoritative and well-organised information may be better placed as discovery behaviour evolves.

The practical response is not to replace SEO, but to extend it. Companies still need strong websites, technically sound pages and useful content. However, they also need to think about how clearly their brand, products, specialists and areas of expertise are defined across the digital environment. Consistent entity recognition matters because AI systems need to understand what an organisation is, what it offers and why its content should be considered reliable.

The rise of GEO points to a wider change in how digital value is measured. Website visits, conversions and rankings remain important indicators, but they do not capture every interaction that influences perception or decision-making. As AI-generated answers become more common, companies may need broader ways to assess visibility, authority and share of voice outside traditional web analytics.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines uses AI to turn medical congress discussions into pharma insights

Talking Medicines uses AI to analyse healthcare professional conversations at medical congresses, turning discussions into structured insights that help...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Search